Who has invested in ImmunoGenesis?

Cancer Focus Fund, BioAdvance, GenH are named among the investors backing ImmunoGenesis.

ImmunoGenesis Funding: $70M Raised, Investors & Rounds

ImmunoGenesis funding overview

ImmunoGenesis is a Biotech company based in Houston, Texas. ImmunoGenesis has raised $70M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Investors on record include Cancer Focus Fund, BioAdvance, GenH. 3 distinct backers are named across the disclosed rounds.

ImmunoGenesis at a glance

Total raised: $70M
Industry: Biotech
Headquarters: Houston, Texas
Notable investors: Cancer Focus Fund, BioAdvance, GenH

Frequently asked about ImmunoGenesis funding

How much has ImmunoGenesis raised?: ImmunoGenesis has raised $70M in total disclosed funding across the rounds on record.
Who has invested in ImmunoGenesis?: Cancer Focus Fund, BioAdvance, GenH are named among the investors backing ImmunoGenesis.
What was the latest ImmunoGenesis funding round?: No round stage has been disclosed for ImmunoGenesis.
Where is ImmunoGenesis based?: ImmunoGenesis is based in Houston, Texas.
What sector does ImmunoGenesis operate in?: ImmunoGenesis is tracked under Biotech from Houston, Texas, with $70M in disclosed funding.

Every ImmunoGenesis figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Houston at a similar stage.

ImmunoGenesis Funding: $70M Raised, Investors & Rounds

ImmunoGenesis funding overview

ImmunoGenesis at a glance

Frequently asked about ImmunoGenesis funding

ImmunoGenesis founders (1)

Companies related to ImmunoGenesis (37)

Browse related funding lists (1)